Regulus Therapeutics Inc.

Historical 13F Holders

Symbol
RGLS
CUSIP
75915K309
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 75915K309 since 12/18/2024, newest first.

Filer % of Class Filed
Deep Track Capital, LP 13G/A Amendment 1
0% 8/14/2025
Event 6/30/2025
Point72 Asset Management, L.P. 13G/A Amendment 1
0.3% 8/14/2025
Event 6/30/2025
Vivo Opportunity Fund Holdings, L.P. 13G/A Amendment 1
3.9% 5/15/2025
Event 3/31/2025
Point72 Asset Management, L.P. 13G
5.9% 4/8/2025
Event 4/1/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 3 0 $760.00
2025 Q1 80 53.6 M $105 M
2024 Q4 72 53.5 M $84.5 M
2024 Q3 77 56.8 M $89.2 M
2024 Q2 70 55.0 M $98.1 M
2024 Q1 52 45.7 M $129 M
2023 Q4 30 9.17 M $11.7 M
2023 Q3 28 8.96 M $12.3 M
2023 Q2 28 8.23 M $12.1 M
2023 Q1 28 6.60 M $5.59 M
2022 Q4 32 6.71 M $9.20 M
2022 Q3 26 6.67 M $11.3 M
2022 Q2 29 4.62 M $9.57 M